Abstract
To explore the clinicopathological characteristics, survival outcomes, and prognosis of very young gastric cancer (GC). From January 1, 2011 to January 1, 2021, GC patients under 30 years old treated in three tertiary hospitals were enrolled. Clinicopathological characteristics were summarized, prognostic factors and survival outcomes including overall survival (OS), disease-free survival (DFS), and progression-free survival (PFS) were retrospectively analyzed. One hundred patients were finally included, with a median age of 23 years.73 (73.0%) were female. Most patients had initial symptoms of abdominal pain (66.0%). The most common tumor locations were gastric antrum (38.0%) and gastric body (37.0%). The main histological types were diffuse (81.0%) and poorly differentiated (91.0%). Most patients presented with stage III–IV disease (82.0%) at diagnosis and the common sites of metastasis were ovary (39.5%) and peritoneum (27.6%). The mOS of the whole group was 23.3 months (95% CI 17.2–29.4). Moreover, the mOS of patients at stage I–II was not reached. The mOS of patients at stage III and stage IV was 40.6 months (95% CI 10.2–70.9) and 10.3 months (95% CI 8.9–11.6), respectively. The mDFS of stage I–III patients was 28.5 months (95% CI 14.7–42.3), and the mPFS of the metastatic patients was 4.5 months (95% CI 4.0–5.0). TNM stage (P = 0.005) and radical surgery (P = 0.001) were independent prognostic factors of overall survival. The very young GC were predominantly female, diffuse type, and advanced diagnosis. TNM stage and radical surgery were independent prognosis factors for overall survival.
Similar content being viewed by others
References
Ferlay J, Colombet M, Soerjomataram I, et al. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
Machlowska J, Baj J, Sitarz M, Maciejewski R, Sitarz R. Gastric cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies. Int J Mol Sci. 2020;21(11):4012.
Sites AJB. SEER cancer statistics review 1975–2011. MD: National Cancer Institute. 2014.
Li J. Gastric cancer in young adults: a different clinical entity from carcinogenesis to prognosis. Gastroenterol Res Pract. 2020;2020:9512707.
Wong M, Huang J, Chan P, et al. Global incidence and mortality of gastric cancer, 1980–2018. JAMA Netw Open. 2021;4(7): e2118457.
Wang Z, Xu J, Shi Z, et al. Clinicopathologic characteristics and prognostic of gastric cancer in young patients. Scand J Gastroenterol. 2016;51(9):1043–9.
Kong X, Wang JL, Chen HM, Fang JY. Comparison of the clinicopathological characteristics of young and elderly patients with gastric carcinoma: a meta analysis. J Surg Oncol. 2012;106(3):346–52.
Lee J, Kim S, Eun C, et al. Impact of age on stage-specific mortality in patients with gastric cancer: a long-term prospective cohort study. PLoS ONE. 2019;14(8): e0220660.
Zhang J, Gan L, Xu MD, et al. The prognostic value of age in non-metastatic gastric cancer after gastrectomy: a retrospective study in the U.S. and China. J Cancer. 2018;9(7):1188–99.
Tekesin K, Emin Gunes M, Tural D, et al. Clinicopathological characteristics, prognosis and survival outcome of gastric cancer in young patients: a large cohort retrospective study. J BUON. 2019;24(2):672–8.
Al-Refaie W, Hu C, Pisters P, Chang G. Gastric adenocarcinoma in young patients: a population-based appraisal. Ann Surg Oncol. 2011;18(10):2800–7.
Zhao B, Zhang J, Zhang J, et al. Assessment of the 8th edition of TNM staging system for gastric cancer: the results from the SEER and a single-institution database. Future Oncol (London, England). 2018;14(29):3023–35.
Zhao B, Mei D, Lv W, et al. Clinicopathologic features, survival outcome, and prognostic factors in gastric cancer patients 18–40 years of age. J Adolesc Young Adult Oncol. 2020;9(4):514–21.
Zhou L, Jiang Z, Gu W, Han S. STROBE-clinical characteristics and prognosis factors of gastric cancer in young patients aged </=30 years. Medicine (Baltimore). 2021;100(26):e26336.
Derakhshan M, Liptrot S, Paul J, Brown I, Morrison D, McColl K. Oesophageal and gastric intestinal-type adenocarcinomas show the same male predominance due to a 17 year delayed development in females. Gut. 2009;58(1):16–23.
Maeta M, Yamashiro H, Oka A, Tsujitani S, Ikeguchi M, Kaibara N. Gastric cancer in the young, with special reference to 14 pregnancy-associated cases: analysis based on 2,325 consecutive cases of gastric cancer. J Surg Oncol. 1995;58(3):191–5.
Ueo H, Matsuoka H, Tamura S, Sato K, Tsunematsu Y, Kato T. Prognosis in gastric cancer associated with pregnancy. World J Surg. 1991;15(2):293–7 (discussion 8).
Jaspers V, Gillessen A, Quakernack K. Gastric cancer in pregnancy: do pregnancy, age or female sex alter the prognosis? Case reports and review. Eur J Obstet Gynecol Reprod Biol. 1999;87(1):13–22.
Yaghoobi M, Rakhshani N, Sadr F, et al. Hereditary risk factors for the development of gastric cancer in younger patients. BMC Gastroenterol. 2004;4:28.
Mun DG, Bhin J, Kim S, et al. Proteogenomic characterization of human early-onset gastric cancer. Cancer Cell. 2019;35(1):111-24 e10.
Chang W, Yeh Y, Sheu B. The impacts of H. pylori virulence factors on the development of gastroduodenal diseases. J Biomed Sci. 2018;25(1):68.
Blaser M, Falkow S. What are the consequences of the disappearing human microbiota? Nat Rev Microbiol. 2009;7(12):887–94.
Moelans CB, Milne AN, Morsink FH, Offerhaus GJ, van Diest PJ. Low frequency of HER2 amplification and overexpression in early onset gastric cancer. Cell Oncol (Dordr). 2011;34(2):89–95.
Moore A, Hikri E, Goshen-Lago T, et al. Young-onset gastric cancer and Epstein-Barr Virus (EBV)—a major player in the pathogenesis? BMC Cancer. 2020;20(1):34.
Guan W, Yuan L, Yan X, Yang D, Qiu M. More attention should be paid to adult gastric cancer patients younger than 35 years old: extremely poor prognosis was found. J Cancer. 2019;10(2):472–8.
Cho S, Park J, Liu Y, et al. Sporadic early-onset diffuse gastric cancers have high frequency of somatic CDH1 alterations, but low frequency of somatic RHOA mutations compared with late-onset cancers. Gastroenterology. 2017;153(2):536-49.e26.
Feng F, Sun L, Liu Z, et al. Prognostic values of normal preoperative serum cancer markers for gastric cancer. Oncotarget. 2016;7(36):58459–69.
Hayden JD, Cawkwell L, Sue-Ling H, et al. Assessment of microsatellite alterations in young patients with gastric adenocarcinoma. Cancer. 1997;79(4):684–7.
Cancer Genome Atlas Research N. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513(7517):202–9.
Funding
The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. The idea of the study was put forward by JL; Data collection and analysis and the first draft of the manuscript were performed by NZ. The manuscript was revised and polished by YY and JC; YS and ZP contributed to date collection. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no relevant financial or non-financial interests to disclose.
Ethics approval
The ethical committee of each hospital approved the study and informed consents were obtained from all the patients.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zhong, N., Yu, Y., Chen, J. et al. Clinicopathological characteristics, survival outcome and prognostic factors of very young gastric cancer. Clin Exp Med 23, 437–445 (2023). https://doi.org/10.1007/s10238-022-00822-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10238-022-00822-3